Deal Library / Pharma BD Deal Intelligence
Otsuka Pharmaceutical Co., Ltd. — Pharma Deals
The Pharma Closeout tracks 6 deals, $6.9B in disclosed deal value, 1 with a post-close Outcome Score for Otsuka Pharmaceutical Co., Ltd..
Median Critic Score: 82 · Median Outcome Score: 41
All 6 deals
- Otsuka Pharmaceutical Co., Ltd. / Avanir Pharmaceuticals, Inc. — 2014 · $3.5B · Underwhelmed — fell short of the thesis.
- Otsuka Pharmaceutical Co., Ltd. / Transcend Therapeutics, Inc. — 2026 · $1.2B
- Otsuka Pharmaceutical Co., Ltd. / 4D Molecular Therapeutics, Inc. — 2025 · $421M
- Otsuka Pharmaceutical Co., Ltd. / Cantargia AB — 2025 · $613M
- Otsuka Pharmaceutical Co., Ltd. / iBio, Inc. — 2024
- Otsuka Pharmaceutical Co., Ltd. / Jnana Therapeutics Inc. — 2024 · $1.1B
← Deal Library ·
Interactive search ·
How we score deals